Credit Suisse’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-59,152
| Closed | -$183K | – | 4569 |
|
|
2021
Q4 | $183K | Sell |
59,152
-6,225
| -10% | -$20.9K | ﹤0.01% | 4295 |
|
|
2021
Q3 | $236K | Buy |
65,377
+3,010
| +5% | +$11.4K | ﹤0.01% | 4171 |
|
|
2021
Q2 | $222K | Buy |
62,367
+706
| +1% | +$2.49K | ﹤0.01% | 4249 |
|
|
2021
Q1 | $240K | Sell |
61,661
-33,142
| -35% | -$137K | ﹤0.01% | 4071 |
|
|
2020
Q4 | $398K | Buy |
94,803
+29,055
| +44% | +$112K | ﹤0.01% | 3890 |
|
|
2020
Q3 | $245K | Buy |
65,748
+10,544
| +19% | +$44.9K | ﹤0.01% | 3757 |
|
|
2020
Q2 | $240K | Sell |
55,204
-31,371
| -36% | -$141K | ﹤0.01% | 3676 |
|
|
2020
Q1 | $328K | Sell |
86,575
-14,365
| -14% | -$70.6K | ﹤0.01% | 3374 |
|
|
2019
Q4 | $639K | Buy |
100,940
+79,381
| +368% | +$467K | ﹤0.01% | 3422 |
|
|
2019
Q3 | $90K | Buy |
21,559
+8,026
| +59% | +$34.3K | ﹤0.01% | 3981 |
|
|
2019
Q2 | $63K | Buy |
+13,533
| New | +$63K | ﹤0.01% | 3981 |
|
|
2017
Q1 | – | Sell |
-73,233
| Closed | -$129K | – | 4306 |
|
|
2016
Q4 | $129K | Buy |
73,233
+61,584
| +529% | +$126K | ﹤0.01% | 3909 |
|
|
2016
Q3 | $31K | Sell |
11,649
-133,167
| -92% | -$338K | ﹤0.01% | 4046 |
|
|
2016
Q2 | $342K | Buy |
144,816
+122,643
| +553% | +$338K | ﹤0.01% | 3638 |
|
|
2016
Q1 | $71K | Sell |
22,173
-125,523
| -85% | -$464K | ﹤0.01% | 3866 |
|
|
2015
Q4 | $707K | Buy |
147,696
+89,043
| +152% | +$505K | ﹤0.01% | 3111 |
|
|
2015
Q3 | $327K | Sell |
58,653
-14,544
| -20% | -$107K | ﹤0.01% | 3670 |
|
|
2015
Q2 | $582K | Buy |
73,197
+27,045
| +59% | +$232K | ﹤0.01% | 3606 |
|
|
2015
Q1 | $485K | Sell |
46,152
-43,438
| -48% | -$593K | ﹤0.01% | 3555 |
|
|
2014
Q4 | $1.08M | Buy |
89,590
+716
| +0.8% | +$10.9K | ﹤0.01% | 3078 |
|
|
2014
Q3 | $1.52M | Sell |
88,874
-75,415
| -46% | -$1.09M | ﹤0.01% | 2703 |
|
|
2014
Q2 | $1.98M | Buy |
164,289
+10,336
| +7% | +$98K | ﹤0.01% | 2723 |
|
|
2014
Q1 | $1.3M | Buy |
153,953
+130,055
| +544% | +$1.05M | ﹤0.01% | 2879 |
|
|
2013
Q4 | $141K | Buy |
+23,898
| New | +$123K | ﹤0.01% | 4414 |
|
Other funds holding BDSI
Credit Suisse's BDSI Position: Q1 2022 in Review
Credit Suisse sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 59,152 shares — an estimated $183K sold.
Credit Suisse first reported a position in BDSI in Q4 2013 and held it in 24 quarters. The position peaked at $1.98M in Q2 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Credit Suisse reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Credit Suisse sold 59,152 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $183K.
- Credit Suisse first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 24 quarters.
- Credit Suisse's BioDelivery Sciences International, Inc. position peaked at $1.98M in Q2 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.